147 related articles for article (PubMed ID: 11325081)
1. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.
Sato A; Takane H; Saruta T
Hypertens Res; 2001 Mar; 24(2):99-104. PubMed ID: 11325081
[TBL] [Abstract][Full Text] [Related]
2. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
Sato A; Hayashi M; Saruta T
Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
[TBL] [Abstract][Full Text] [Related]
3. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
Sasaguri M; Noda K; Tashiro E; Notomo J; Tsuji E; Koga M; Arakawa K
Hypertens Res; 2000 Jul; 23(4):317-22. PubMed ID: 10912767
[TBL] [Abstract][Full Text] [Related]
4. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
Sato A; Suzuki Y; Saruta T
Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
[TBL] [Abstract][Full Text] [Related]
6. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta in hypertensives with cardiorenal damage.
Laviades C; Varo N; Díez J
Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.
Nakahara T; Takata Y; Hirayama Y; Asano K; Adachi H; Shiokawa G; Sumi T; Ogawa T; Yamashina A
Circ J; 2007 May; 71(5):716-21. PubMed ID: 17456997
[TBL] [Abstract][Full Text] [Related]
9. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
[TBL] [Abstract][Full Text] [Related]
10. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
Gupta A; Schiros CG; Gaddam KK; Aban I; Denney TS; Lloyd SG; Oparil S; Dell'Italia LJ; Calhoun DA; Gupta H
J Hum Hypertens; 2015 Apr; 29(4):241-6. PubMed ID: 25231508
[TBL] [Abstract][Full Text] [Related]
11. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.
Ferreira JP; Rossignol P; Pizard A; Machu JL; Collier T; Girerd N; Huby AC; Gonzalez A; Diez J; López B; Sattar N; Cleland JG; Sever PS; Zannad F
Heart; 2019 Feb; 105(4):307-314. PubMed ID: 30121630
[TBL] [Abstract][Full Text] [Related]
12. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Matsui T; Kinoshita M
J Am Coll Cardiol; 2001 Apr; 37(5):1228-33. PubMed ID: 11300427
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.
Sato A; Saruta T
J Int Med Res; 2001; 29(1):13-21. PubMed ID: 11277342
[TBL] [Abstract][Full Text] [Related]
14. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients.
MacFadyen RJ; Barr CS; Struthers AD
Cardiovasc Res; 1997 Jul; 35(1):30-4. PubMed ID: 9302344
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between myocardial modelling and diastolic function in patients with essential hypertension].
Cortés R; Roselló-Lletí E; Portolés M; Almenar L; Martínez-Dolz L; Grigorian L; García de Burgos F; Carpena N; Salvador A; Bertomeu V; Rivera M
Med Clin (Barc); 2012 Oct; 139(8):325-30. PubMed ID: 22036455
[TBL] [Abstract][Full Text] [Related]
17. Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.
Cavallari LH; Momary KM; Groo VL; Viana MA; Camp JR; Stamos TD
Pharmacotherapy; 2007 Jun; 27(6):801-12. PubMed ID: 17542763
[TBL] [Abstract][Full Text] [Related]
18. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
[TBL] [Abstract][Full Text] [Related]
19. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients.
Díez J; Laviades C; Monreal I; Gil MJ; Panizo A; Pardo J
Am J Cardiol; 1995 Nov; 76(13):14D-17D. PubMed ID: 7495211
[TBL] [Abstract][Full Text] [Related]
20. Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy.
Timms PM; Wright A; Maxwell P; Campbell S; Dawnay AB; Srikanthan V
Am J Hypertens; 2002 Mar; 15(3):269-72. PubMed ID: 11939619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
